博文
胰腺癌治疗国际学术讨论网络直播
||
| |||||||||||||||||
| |||||||||||||||||
| New Data on Chemotherapeutic Options Mean New Choices for Advanced Pancreatic Cancer: How Do the Experts Decide? | |||||||||||||||||
| |||||||||||||||||
| Thursday, January 23, 2014 5:00 – 6:00 PM (Central European Time): Webcast | |||||||||||||||||
| Agenda Welcome and Introduction The panel moderator will provide an overview of the programme, noting that the presentations will explore recent data and how these translate to real-world patient care. The moderator will also explain the web broadcast functionality and inform the audience of their ability to submit questions for the “Ask the Faculty” portion of the agenda. What’s New in Chemotherapy for Advanced Pancreatic Cancer: A Review of Recently Presented Survival Data In the first presentation, the expert faculty will briefly review recently presented survival data for therapies approved and in development for advanced pancreatic cancer. As the faculty move through these data, the panel of experts will discuss the impact these data may have on patient care, including the psychological impact of improved survival outcomes. Individualising Care in Advanced Pancreatic Cancer: A Review of Response Rate and How to Individualise Care in Your Patient In the second presentation, the expert faculty will review recently presented response data and discuss how to measure response to therapies approved and in development for advanced pancreatic cancer, focusing on patients who may benefit from early disease control. Using these recent findings, the expert faculty will then also illustrate how to select therapy based on patient and drug characteristics. A Longitudinal Case Study in Advanced Pancreatic Cancer: A Review of Experts’ Decision Tree and Guideline Recommendations In the third presentation, the expert faculty panel will take a more in-depth look at a patient, moving from diagnosis through multiple lines of treatment, and provide their insights on key decision points. The virtual audience will have the opportunity to vote at certain points in the decision tree. This case-based discussion among the faculty experts will illustrate effective ways to integrate and adapt the learnings previously discussed, as well as treatment guidelines, into clinical practice Conclusions and Q&A Session The faculty will answer questions submitted by the virtual audience. The meeting will conclude with key take-away messages from the faculty moderator. | |||||||||||||||||
How to Register for This Activity
| |||||||||||||||||
| |||||||||||||||||
| This activity is supported by an educational grant from Celgene International Sàrl. | |||||||||||||||||
| PeerVoice activities are designed to fill the unmet needs of the medical community by reporting information pertaining to clinically relevant advances and developments in the science and practice of medicine. The preparation of PeerVoice activities is supported by written agreements that clearly stipulate and enforce the editorial independence of PeerVoice and the faculty presenters. | |||||||||||||||||
| Unsubscribe || Privacy Policy || Not a Subscriber? To prevent mailbox filters from deleting your PeerVoice e-newsletter, addwebmaster@peervoice.com to your address book now. © 2010-2013, PeerVoice 1140 Avenue of the Americas, 15th Floor, New York, NY 10036 |
|
https://wap.sciencenet.cn/blog-280034-749664.html
上一篇：科学网电子杂志2013332期
下一篇：预防癌症很简单
扫一扫，分享此博文
全部作者的精选博文
全部作者的其他最新博文
- • 生物医学科研动态 4月30日
- • 诗书画 创作 35
- • 生物医学科研动态 4月29日
- • 诗书画 创作 34
- • 生物医学科研动态 4月28日
- • 诗书画创作 33